December 19, 2024 Press Releases Glycosyn announces the availability for licensing of its commercial high-titer human milk oligosaccharide (HMO) production strains, and IP covering prebiotic, anti-inflammatory and anti-infective uses of HMOs
September 13, 2019 Press Releases Processes To Make Key Ingredient In Similac® Baby Formula Are Protected
November 8, 2018 Press Releases Ginkgo Bioworks and Glycosyn LLC Announce $14MM Deal to Scale Production of Human Milk Oligosaccharides
February 11, 2016 Press Releases FrieslandCampina and Glycosyn partner for new infant nutrition ingredients
